Cost-utility analysis of nanoparticle albumin-bound paclitaxel (nab-paclitaxel) in combination with gemcitabine in metastatic pancreatic cancer in Spain: Results of the PANCOSTABRAX study

López López, Rafael

Statistics

Statistics

View Usage Statistics

Identifiers

Identifiers

URI: http://hdl.handle.net/20.500.11940/8161

PMID: 25991037

DOI: 10.1586/14737167.2015.1047349

ISSN: 1473-7167

Full record

Services

Services

RIS

Mendeley

Linksolver

Date issued

2015

Journal title

Expert review of pharmacoeconomics & outcomes research

Type of content

Artigo